Health Care

2118 articles

Featured

Johnson & Johnson heads into Q4 as a more focused healthcare leader

Johnson & Johnson (NYSE: JNJ) is capitalizing on its transition from a broad-based healthcare conglomerate into a market leader in…

Staff Correspondent | January 12, 2026 | 3 min read

Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of...

January 6, 2026 | 1 min read

Everything you need to know about Aktis Oncology’s upcoming IPO

IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors, after last year’s sluggish performance....

December 26, 2025 | 2 min read

Pfizer affirms FY25 earnings guidance, provides full-year 2026 outlook

Pfizer Inc. (NYSE: PFE) has reaffirmed its earnings outlook for fiscal 2025 and revised revenue guidance. The pharma giant also...

December 17, 2025 | 1 min read

Everything you need to know about Medline’s IPO

After a modest start to the year, IPO activity rebounded in the second half of the year as recession fears...

December 16, 2025 | 2 min read

Unicycive is all-in on kidney care, focusing on underserved areas: CEO

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is a biotech firm engaged in the development of novel treatment options for patients with...

December 11, 2025 | 5 min read

CVS Health raises guidance for FY25 revenue and adjusted earnings

Healthcare services company CVS Health (NYSE: CVS) has updated its 2025 full-year financial guidance and issued forecasts for fiscal 2026....

December 9, 2025 | 1 min read

IPO News: What to look for when Lumexa Imaging goes public

IPO activity rebounded in the second half of the year, with the technology and healthcare sectors maintaining their dominance in...

December 9, 2025 | 2 min read

Earnings Summary: CooperCompanies reports higher Q4 revenue, adj. profit

CooperCompanies (NYSE: COO) has reported an increase in revenues and adjusted earnings for the fourth quarter of fiscal 2025. The...

December 8, 2025 | 1 min read

MDT Earnings: Medtronic Q2 FY26 revenue and adj. profit beat estimates

Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues and adjusted earnings for the second quarter of...

November 18, 2025 | 1 min read

Advantage of CERo’s CER receptor lies in native human protein-based antigen binding: CEO

CERo Therapeutics Holdings, Inc. is a biotechnology company pioneering engineered T cell immunotherapies to combat cancer, with a focus on...

November 12, 2025 | 6 min read

Viatris (VTRS) posts Q3 2025 results and updates 2025 guidance

Pharmaceuticals company Viatris Inc. (NASDAQ: VTRS) on Thursday reported financial results for the third quarter of fiscal 2025, and updated...

November 6, 2025 | 1 min read

Earnings Summary: Humana Q3 2025 profit drops despite higher revenues

Humana Inc. (NYSE: HUM), a leading health and well-being company, on Wednesday reported a decline in adjusted earnings for the...

November 5, 2025 | 1 min read

Key takeaways from Pfizer’s (PFE) Q3 2025 earnings report

Shares of Pfizer Inc. (NYSE: PFE) stayed green during midday trade on Tuesday following the company’s announcement of its third...

November 4, 2025 | 2 min read

PFE Earnings: All you need to know about Pfizer’s Q3 2025 earnings results

Pfizer Inc. (NYSE: PFE) reported its third quarter 2025 earnings results today. Revenues were $16.7 billion, down 6% on a...

November 4, 2025 | 1 min read

Earnings Summary: Highlights of IDEXX’s Q3 2025 report

Medical device company IDEXX Laboratories, Inc. (NASDAQ: IDXX) on Monday reported higher revenues and earnings for the third quarter of...

November 3, 2025 | 1 min read

ABBV Earnings: A snapshot of AbbVie’s Q3 2025 report

Pharmaceuticals company AbbVie, Inc. (NYSE: ABBV) on Friday reported a decline in earnings for the third quarter of fiscal 2025,...

October 31, 2025 | 1 min read

BIIB Earnings: A snapshot of Biogen’s Q3 2025 results

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported an increase in adjusted profit for the third quarter of 2025 when its...

October 30, 2025 | 1 min read

Earnings Summary: Cardinal Health Q1 2026 revenue jumps 22%; raises guidance

Pharmaceuticals distributor Cardinal Health (NYSE: CAH) reported a sharp increase in revenue and adjusted earnings for the first quarter of...

October 30, 2025 | 1 min read

Bristol Myers Squibb (BMY) Earnings: 3Q25 Key Numbers

Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2025 earnings results today. Revenues increased 3% year-over-year to $12.2 billion....

October 30, 2025 | 1 min read

Eli Lilly (LLY) Earnings: 3Q25 Key Numbers

Eli Lilly and Company (NYSE: LLY) reported its third quarter 2025 earnings results today. Worldwide revenue was $17.60 billion, up...

October 30, 2025 | 1 min read